Physician profile
Jonathan M Moskovits
NPI 1275889867
$12,548.14
in general payments reported to CMS, 2019-2025
24 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $495 · 2021: $2,296 · 2022: $2,662 · 2023: $3,047 · 2024: $1,596 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,384 · Travel and Lodging: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,384.27 |
| Travel and Lodging | $584.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,170.14 | 2019-2025 | Gravity, Gravity Synchfix, Inbone |
| Integra Lifesciences Corporation | $2,429.06 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $1,330.64 | 2021-2025 | |
| Organogenesis INC. | $1,101.08 | 2019-2024 | Puraply |
| Orthofix Medical, INC. | $621.84 | 2020-2025 | Physio-Stim |
| Smith+Nephew, INC. | $582.71 | 2020-2024 | Collagenase Santyl, Regranex, Stravix |
| Abbott Laboratories | $280.04 | 2023-2025 | Proclaim, Esprit |
| Linvatec Corporation | $265.55 | 2023 | 5ms, Colink Afx, In2bones USA |
| Acera Surgical, INC. | $242.16 | 2020-2025 | Restrata Wound Matrix |
| Djo, LLC | $240.58 | 2021-2025 | Cmf |
| Polynovo North America LLC | $206.38 | 2025 | Novosorb Btm |
| Wright Medical Technology, INC. | $158.97 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $150.00 | 2024 | Rotarexs 6 F X 135 Cm |
| Horizon Therapeutics Plc | $145.76 | 2020-2021 | |
| Paragon 28, INC. | $127.24 | 2025 | Monkey Bars |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $121.92 | 2023 | Nuzyra |
| Osiris Therapeutics INC. | $119.47 | 2019 | |
| Kerecis Limited | $93.70 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Globus Medical, INC. | $66.61 | 2024 | Allocate |
| Bioventus LLC | $31.39 | 2020 | |
| Medshape, INC. | $26.32 | 2022 | |
| Mimedx Group, INC. | $15.13 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $13.96 | 2021 | |
| Ossdsign USA Incorporated | $7.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moskovits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.